Stock listing
Middle East Pharmaceutical Industries Company
Selected listing: 4016 · TADAWUL · SAR · SA
Middle East Pharmaceutical Industries Company (TADAWUL:4016), Health Technology. Latest release May 6, 2026: Avalon Pharma Q1 Profit SAR 26.9 Million.
- Ticker
- TADAWUL:4016
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TADAWUL
- Currency
- SAR
About Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company, traded under the ticker 4016 on the KSA market, specializes in the production and distribution of pharmaceutical products. It focuses on delivering high-quality healthcare solutions to meet the needs of its customers in the region.
Latest news from Middle East Pharmaceutical Industries Company
Avalon Pharma Q1 Profit SAR 26.9 Million
May 6, 2026
Avalon Pharma Appoints Ahmad Shaher Al Tabbaa As Chairman
April 16, 2026
Avalon Pharma H2 Dividend Per Share SAR 1.32
March 8, 2026
Avalon Pharma FY Profit 97.01 Mln Riyals
March 4, 2026
Avalon Pharma Contract Sign Off With Bio-Thera Solutions
February 4, 2026
Research Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company company profile
View the public company page for Middle East Pharmaceutical Industries Company on 6ix.
Middle East Pharmaceutical Industries Company news
Read company news and market updates connected to Middle East Pharmaceutical Industries Company.
Middle East Pharmaceutical Industries Company investor events
Find investor webinars, events, and replay context for Middle East Pharmaceutical Industries Company.